![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
RG Moran, PD Colman, A Rosowsky, RA Forsch and KK Chan
The activity of a series of folic acid analogues as substrates for partially purified mouse liver folylpolyglutamate synthetase was determined and the effects of substituents on the binding to, and catalytic processes of, this enzyme were inferred. A 4-amino group improved substrate activity primarily by decreasing the apparent Km while N10-methyl substitution substantially diminished utilization as a substrate, again, by effects on Km. Isosteric replacement of N-10 altered substrate activity. A free alpha-carboxyl group in the amino acid side chain was required for catalysis as was the presence of the side chain amide carbonyl group. Modification of the amino acid side chain length profoundly affected activity. Several observations were made that may be relevant to chemotherapy with folate antimetabolites: 1) 7-hydroxymethotrexate was a substrate for this enzyme; 2) substrate activity and substrate inhibition were observed with CB 3717, a potent inhibitor of thymidylate synthase; 3) potent classical dihydrofolate reductase inhibitors were identified that were either not substrates for mouse liver folylpolyglutamate synthetase (e.g., 4-amino-4-deoxy- N10-methylpteroyl-L-alpha-aminoadipate) or were much better substrates than methotrexate for this enzyme (e.g., aminopterin); and 4) leucovorin and methotrexate appeared to be substrates for the same synthetase, but leucovorin saturated the reaction at much lower concentrations. These results have implications for the design of folylpolyglutamate synthetase inhibitors and for the selection of dihydrofolate reductase inhibitors that are either not polyglutamated or are efficiently polyglutamated in vivo.
This article has been cited by other articles:
|
|
 |
|
  P. D. Cole, R. A. Drachtman, A. K. Smith, S. Cate, R. A. Larson, D. S. Hawkins, J. Holcenberg, K. Kelly, and B. A. Kamen Phase II Trial of Oral Aminopterin for Adults and Children with Refractory Acute Leukemia Clin. Cancer Res., November 15, 2005; 11(22): 8089 - 8096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Leclerc and J. C. Barredo Folylpoly-{{gamma}}-glutamate Synthetase Gene mRNA Splice Variants and Protein Expression in Primary Human Leukemia Cells, Cell Lines, and Normal Human Tissues Clin. Cancer Res., April 1, 2001; 7(4): 942 - 951. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Tse and R. G. Moran Cellular Folates Prevent Polyglutamation of 5,10-Dideazatetrahydrofolate. A NOVEL MECHANISM OF RESISTANCE TO FOLATE ANTIMETABOLITES J. Biol. Chem., October 2, 1998; 273(40): 25944 - 25952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Roy, M. G. Egan, S. Sirlin, and F. M. Sirotnak Posttranscriptionally Mediated Decreases in Folylpolyglutamate Synthetase Gene Expression in Some Folate Analogue-resistant Variants of the L1210 Cell. EVIDENCE FOR AN ALTERED COGNATE mRNA IN THE VARIANTS AFFECTING THE RATE OF DE NOVO SYNTHESIS OF THE ENZYME J. Biol. Chem., March 14, 1997; 272(11): 6903 - 6908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Roy, K. Mitsugi, and F. M. Sirotnak Organization and Alternate Splicing of the Murine Folylpolyglutamate Synthetase Gene. DIFFERENT SPLICE VARIANTS IN L1210 CELLS ENCODE MITOCHONDRIAL OR CYTOSOLIC FORMS OF THE ENZYME J. Biol. Chem., September 27, 1996; 271(39): 23820 - 23827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chen, H. Qi, J. Korenberg, T. A. Garrow, Y.-J. Choi, and B. Shane Purification and Properties of Human Cytosolic Folylpoly-gamma -glutamate Synthetase and Organization, Localization, and Differential Splicing of Its Gene J. Biol. Chem., May 31, 1996; 271(22): 13077 - 13087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Roy, K. Mitsugi, S. Sirlin, B. Shane, and F. M. Sirotnak Different Antifolate-resistant L1210 Cell Variants with either Increased or Decreased Folylpolyglutamate Synthetase Gene Expression at the Level of mRNA Transcription J. Biol. Chem., November 10, 1995; 270(45): 26918 - 26922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Egan, S. Sirlin, B. G. Rumberger, T. A. Garrow, B. Shane, and F. M. Sirotnak Rapid Decline in Folylpolyglutamate Synthetase Activity and Gene Expression during Maturation of HL-60 Cells J. Biol. Chem., March 10, 1995; 270(10): 5462 - 5468. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
